The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring
Authors
Keywords
Liquid biopsy, Liquid biosources, NSCLC, Lung cancer, Diagnostic biomarker, Prognostic biomarker, Predictive biomarker, Resistance biomarker, TEPs, cfDNA, ctDNA, EVs, Exosomes, CTCs
Journal
Current Oncology Reports
Volume 20, Issue 9, Pages -
Publisher
Springer Nature
Online
2018-07-20
DOI
10.1007/s11912-018-0720-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- Pharmacological management of relapsed/refractory NSCLC with chemical drugs
- (2017) Niki Karachaliou et al. EXPERT OPINION ON PHARMACOTHERAPY
- Characterization of single circulating tumor cells
- (2017) Catherine Alix-Panabières et al. FEBS LETTERS
- Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management
- (2017) Julie Vendrell et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Going With the Flow: The Promise and Challenge of Liquid Biopsies
- (2017) M.J. Friedrich JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- Integrating liquid biopsies into the management of cancer
- (2017) Giulia Siravegna et al. Nature Reviews Clinical Oncology
- Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies
- (2017) Emmet J. Jordan et al. Cancer Discovery
- Possible application of circulating free tumor DNA in non-small cell lung cancer patients
- (2017) Niki Karachaliou et al. Journal of Thoracic Disease
- High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells
- (2017) Eric Lin et al. Cell Systems
- Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation
- (2016) Heidi D. Nelson et al. ANNALS OF INTERNAL MEDICINE
- Psychological Burden Associated With Lung Cancer Screening: A Systematic Review
- (2016) Geena X. Wu et al. Clinical Lung Cancer
- New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
- (2016) Erika Larrea et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Large-scale screening for somatic mutations in lung cancer
- (2016) Rafael Rosell et al. LANCET
- Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study
- (2016) Glenwood Goss et al. LANCET ONCOLOGY
- An ultra-deep sequencing strategy to detect sub-clonal TP53 mutations in presentation chronic lymphocytic leukaemia cases using multiple polymerases
- (2016) L Worrillow et al. ONCOGENE
- First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer
- (2016) Keunchil Park et al. JAMA Oncology
- Prospective Validation of Rapid Plasma Genotyping for the Detection ofEGFRandKRASMutations in Advanced Lung Cancer
- (2016) Adrian G. Sacher et al. JAMA Oncology
- Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography
- (2015) Maurizio Infante et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- First-line erlotinib versus gemcitabine/cisplatin in patients with advancedEGFRmutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study
- (2015) Y.-L. Wu et al. ANNALS OF ONCOLOGY
- RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
- (2015) Myron G. Best et al. CANCER CELL
- Accessing Genetic Information with Liquid Biopsies
- (2015) Xuyu Cai et al. TRENDS IN GENETICS
- Comparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutation
- (2015) BO ZHANG et al. Experimental and Therapeutic Medicine
- Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer
- (2015) R. Jonas A. Nilsson et al. Oncotarget
- Association ofEGFRL858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial
- (2015) Niki Karachaliou et al. JAMA Oncology
- Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA
- (2015) Richard B. Lanman et al. PLoS One
- Liquid biopsies in lung cancer: The new ambrosia of researchers
- (2014) Christian Rolfo et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Platelets and cancer: a casual or causal relationship: revisited
- (2014) David G. Menter et al. CANCER AND METASTASIS REVIEWS
- Double-stranded DNA in exosomes: a novel biomarker in cancer detection
- (2014) Basant Kumar Thakur et al. CELL RESEARCH
- Noninvasive Detection of Response and Resistance in EGFR-Mutant Lung Cancer Using Quantitative Next-Generation Genotyping of Cell-Free Plasma DNA
- (2014) G. R. Oxnard et al. CLINICAL CANCER RESEARCH
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status
- (2014) Jean-Yves Douillard et al. Journal of Thoracic Oncology
- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
- (2014) Fritz H Schröder et al. LANCET
- Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential
- (2014) Giuseppe Galletti et al. Molecular Diagnosis & Therapy
- The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
- (2014) Sandra S. McAllister et al. NATURE CELL BIOLOGY
- Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
- (2014) C. Bettegowda et al. Science Translational Medicine
- Folate Receptor-Positive Circulating Tumor Cells as a Novel Diagnostic Biomarker in Non-Small Cell Lung Cancer
- (2014) Yue Yu et al. Translational Oncology
- Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
- (2014) D. A. Haber et al. Cancer Discovery
- The benefits and harms of breast cancer screening: an independent review
- (2013) M G Marmot et al. BRITISH JOURNAL OF CANCER
- Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine
- (2013) O. Juan et al. Clinical & Translational Oncology
- Extracellular vesicles: Exosomes, microvesicles, and friends
- (2013) Graça Raposo et al. JOURNAL OF CELL BIOLOGY
- Treatment of early-stage lung cancer detected by screening: surgery or stereotactic ablative radiotherapy?
- (2013) Suresh Senan et al. LANCET ONCOLOGY
- Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non-Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib
- (2012) E. A. Punnoose et al. CLINICAL CANCER RESEARCH
- Annual or biennial CT screening versus observation in heavy smokers
- (2012) Ugo Pastorino et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT
- (2012) Zaigham Saghir et al. THORAX
- NELSON lung cancer screening study
- (2012) Ying Ru Zhao et al. CANCER IMAGING
- Blood platelets contain tumor-derived RNA biomarkers
- (2011) R. J. A. Nilsson et al. BLOOD
- Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method
- (2011) V. Hofman et al. CYTOPATHOLOGY
- Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system
- (2011) E. Andreopoulou et al. INTERNATIONAL JOURNAL OF CANCER
- Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer
- (2011) Matthew G. Krebs et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches
- (2011) Matthew G. Krebs et al. Journal of Thoracic Oncology
- Circulating tumor cells: a window into cancer biology and metastasis
- (2010) Shyamala Maheswaran et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Circulating Tumor Cells in Colorectal Cancer: Past, Present, and Future Challenges
- (2010) Benjamin P. Negin et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Uptake in cancer screening programmes
- (2009) David P Weller et al. LANCET ONCOLOGY
- Management of Lung Nodules Detected by Volume CT Scanning
- (2009) Rob J. van Klaveren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope
- (2008) T G Ntouroupi et al. BRITISH JOURNAL OF CANCER
- Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
- (2008) Johan Skog et al. NATURE CELL BIOLOGY
- Detection of Mutations inEGFRin Circulating Lung-Cancer Cells
- (2008) Shyamala Maheswaran et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now